Aaron Ver Heul, MD
Allergy & Immunology · Saint Louis, MONPI 1023457132
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,738 of the $27,950 with a category attached, or 95.7%. Galderma Laboratories, L.p. accounts for 63.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $24,869 and has fallen 99.8% since, to $48 in 2025. Among allergy & immunology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $1644.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$18K
- Novartis$5K
- Galderma Research & Development, LLC$3K
- Sanofi$2K
- Incyte Corporation$136
- Regeneron Healthcare Solutions, Inc.$71
- plus $17 from 1 others
Across 4 payments — averaging $18,088 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$72K
What the payments were for
- Consulting fees$26,73896%
- Travel & lodging$5392%
- Food & beverage$6732%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 3 | $17,623 |
| Novartis | 7 | $5,071 |
| Galderma Research & Development, LLC | 1 | $2,900 |
| Sanofi | 1 | $2,132 |
| Incyte Corporation | 2 | $136 |
| Regeneron Healthcare Solutions, Inc. | 2 | $71 |
| AstraZeneca | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$2,132
How this compares
$27,950 in reported general payments places this provider in the 90th percentile of 61 allergy & immunology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $43,483 |
| Gabapentin | 17 | $203 |
| Famotidine | 26 | $191 |
| Montelukast Sodium | 21 | $67 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Saint Louis
- H James WednerSaint Louis$420K
- Manoj WarrierSaint Louis$316K
- Jeffrey TillinghastSaint Louis$278K
- Peggy KendallSaint Louis$20K
- Michael BortsSaint Louis$17K
- Jeremy KatcherSaint Louis$16K
- Elyra FigueroaSaint Louis$11K
- Barbara JostSaint Louis$9K
- Maya JerathSaint Louis$9K
- Cheshil DixitSaint Louis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.